S
Sverre E. Kjeldsen
Researcher at University of Oslo
Publications - 771
Citations - 95426
Sverre E. Kjeldsen is an academic researcher from University of Oslo. The author has contributed to research in topics: Blood pressure & Left ventricular hypertrophy. The author has an hindex of 94, co-authored 735 publications receiving 89059 citations. Previous affiliations of Sverre E. Kjeldsen include University of Michigan & Cornell University.
Papers
More filters
Journal ArticleDOI
Effects on plasma noradrenaline may explain some of the improved insulin sensitivity seen by AT-1 receptor blockade.
Tonje A. Aksnes,Arnljot Flaa,Knut Sevre,Haavard Holth Mundal,Morten Rostrup,Sverre E. Kjeldsen +5 more
TL;DR: Improved insulin sensitivity in hypertensives after additional treatment with angiotensin II‐receptor blocker (ARB) compared with calcium‐channel blocker (CCB) alone may be related to decreased plasma noradrenaline and potential sympatholytic effects.
Journal ArticleDOI
Assessment of Insulin Sensitivity by 90 Min Isoglycaemic Hyperinsulinaemic Glucose Clamp in Healthy Young Men
TL;DR: A detailed analysis of the isoglycaemic hyperinsulinaemic glucose clamp in relation to the time spent in performing the procedure was performed and two series performed by independent investigators on different groups were analysed.
Journal ArticleDOI
Hypertension in very old people.
Sverre E. Kjeldsen,Ingrid Os +1 more
TL;DR: It appears that benefit has been shown in elderly patients for at least one representative agent of several drug classes (i.e. diuretics, beta-blockers, calcium antagonists, angiotensin-converting enzyme inhibitors and angiotENSin receptor antagonists) and initiation of antihypertensive treatment in elderly Patients should follow the general guidelines.
Journal ArticleDOI
Long-term effects of a losartan- compared with an atenolol-based treatment regimen on carotid artery plaque development in hypertensive patients with left ventricular hypertrophy: ICARUS, a LIFE substudy.
Eigil Fossum,Michael H. Olsen,Aud Høieggen,K. Wachtell,Henrik M. Reims,Sverre E. Kjeldsen,H. Ibsen,Ying Wan,Stevo Julius +8 more
TL;DR: The small number of patients evaluated may have limited the power to detect a difference in outcome, and the difference in carotid plaque index increase between the treatment groups during 3 years of treatment could not be statistically linked to specific treatments in the present substudy.